Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.

Publication ,  Journal Article
Demmy, TL; Yendamuri, S; D'Amico, TA; Burfeind, WR
Published in: Ann Thorac Surg
August 2018

BACKGROUND: Despite the slow adoption of minimally invasive lobectomy (MIL), it is now a preferred approach for early lung cancer. Nevertheless, ongoing concerns about MIL oncologic effectiveness has led to calls for prospective, randomized trials. METHODS: Retrospective analysis of on-line databases, collected readings, and other scholarly experiences of the experienced authors were used to construct this review. All available reports that contained long-term survival comparisons for open versus MIL were tabulated. RESULTS: The preponderance of limited randomized and numerous large propensity-matched database analyses indicate equivalent or improved long-term MIL survival for early-stage disease. MIL lymph node dissection quality has been challenged; however, this was attributed to MIL avoidance of central tumors in early reports. Although technical inadequacies for MIL should be amplified for advanced cancer resections, early reports show no such concern. In fact, for special populations such as older, frail patients, evidence is much stronger that MIL confers a survival advantage. CONCLUSIONS: MIL is an oncologically equivalent operation with substantially less morbidity, especially in frail populations. It is reasonable to suggest that MIL should be the technique of choice, even a quality indicator, for lobectomy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

August 2018

Volume

106

Issue

2

Start / End Page

609 / 617

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Thoracic Surgery, Video-Assisted
  • Survival Analysis
  • Surgical Oncology
  • Risk Assessment
  • Retrospective Studies
  • Respiratory System
  • Prognosis
  • Pneumonectomy
  • Minimally Invasive Surgical Procedures
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Demmy, T. L., Yendamuri, S., D’Amico, T. A., & Burfeind, W. R. (2018). Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. Ann Thorac Surg, 106(2), 609–617. https://doi.org/10.1016/j.athoracsur.2018.02.089
Demmy, Todd L., Sai Yendamuri, Thomas A. D’Amico, and William R. Burfeind. “Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.Ann Thorac Surg 106, no. 2 (August 2018): 609–17. https://doi.org/10.1016/j.athoracsur.2018.02.089.
Demmy TL, Yendamuri S, D’Amico TA, Burfeind WR. Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. Ann Thorac Surg. 2018 Aug;106(2):609–17.
Demmy, Todd L., et al. “Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.Ann Thorac Surg, vol. 106, no. 2, Aug. 2018, pp. 609–17. Pubmed, doi:10.1016/j.athoracsur.2018.02.089.
Demmy TL, Yendamuri S, D’Amico TA, Burfeind WR. Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. Ann Thorac Surg. 2018 Aug;106(2):609–617.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

August 2018

Volume

106

Issue

2

Start / End Page

609 / 617

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Thoracic Surgery, Video-Assisted
  • Survival Analysis
  • Surgical Oncology
  • Risk Assessment
  • Retrospective Studies
  • Respiratory System
  • Prognosis
  • Pneumonectomy
  • Minimally Invasive Surgical Procedures